Notably, both variants of DS-1594a were highly effective in eradicating tumors and enhancing survival in MOLM-13 cells and xenograft models of KMT2A-r or NPM1-m acute leukemia derived from patients [66]. Here, NPM1 is linked to acute leukemia.